Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.53%
SPX
+0.32%
IXIC
+0.25%
FTSE
-0.13%
N225
-0.04%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
8.27B
Dividend Yield
0.00%
P/E Ratio
-53.08
EPS
-1.04
Revenue
508.82M
Avg. Volume
1.14M

About

What does BPMC do?
Blueprint Medicines, headquartered in Cambridge, Massachusetts, develops precision therapies for cancer and blood disorders, employing 645 fulltime staff. It has approved medicines like AYVAKIT and GAVRETO, with ongoing research in various cancers.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Massachusetts, USA
Website
http://www.blueprintmedicines.com

Recently from Cashu

publisher logo
Cashu

Blueprint Medicines Sees Increased Short Selling Amid Market Uncertainty and Investor Concerns

1 day ago
publisher logo
Cashu

Blueprint Medicines Faces Increased Short Selling Amid Market Uncertainty and Investor Concerns

4 days ago
publisher logo
Cashu

Blueprint Medicines and the Rise of Targeted Therapies in Rare Disease Treatment

6 days ago
Stocks
Health Care
bpmc
Blueprint Medicines
BPMC
+0.02 (+0.02%)
129.37
USD
At close at Jul 16, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials